89.6

Ratko Djukanović

NIHR Southampton Biomedical Research Centre, University of Southampton, University Hospital Southampton NHS Foundation Trust

Ratko Djukanović's research has made significant contributions to the fields of respiratory medicine, immunology, and clinical science. Studies published on radiomultiomics and proteomic signatures have identified quantitative clusters associated with severe asthma, shedding light on mechanistic subtypes of disease and potential biomarkers for treatment. Additionally, work on COVID-19 research, accelerated immune aging, and hemoglobin variations has elucidated factors influencing disease severity and recovery. Research on asthma innovations, lipid composition, and eicosanoids has also provided valuable insights into diagnosis, management, and personalized treatments. These findings have far-reaching implications for improving patient outcomes and informing clinical practice guidelines, benefiting individuals with respiratory conditions and the broader medical community.

AsthmaRespiratoryTreatmentpulmonary diseaseType 2 ImmunityCOPDRegulatory T CellsCough Reflex SensitivityInflammationMucosal ImmunityAdaptive Immune SystemDiagnosislung functionHouse Dust Mite AllergensEosinophils
Firms applying this knowledge

National Jewish Health, Externautics S.P.A., Anges, Inc., University Of Pittsburgh—Of The Commonwealth System Of Higher Education, Progenics Pharmaceuticals, Inc.

Commercial signal 89.5
Scientific signal 91.8
Social signal 86.5
Papers 221
521 Patent-to-paper cites
18,200 Paper cites

scientifiq.ai is an experimental platform. The platform relies on open source data and it may contain errors. Its primary goal is to advance scientific research on innovation.